Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

NCT06280508 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence

Interventions

DRUG: Adebrelimab, Apatinib, Gemcitabine, cisplatin

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University